companies > M > Matrix Laboratories Matrix Laboratories US drug maker Mylan looking to India as key growth hub 28 May 2011 Mylan to rename Matrix Lab as 'Mylan' 27 May 2011 Pfizer, Mylan lower HIV drug prices for drug-resistant patients 08 August 2009 After Matrix who will be delisted next? 28 March 2009 Jagdish Dore new CEO of Matrix Labs 28 February 2008 Matrix Labs may divest Docpharma 28 February 2008 Matrix Labs gets US FDA nod for HIV drug 05 December 2007 Matrix to acquire residual holding in China''s Mchem group 25 August 2007 Mylan completes stake acquisition in Matrix 10 January 2007 JB Chemicals, Matrix Labs in licensing agreement with Gilead Sciences for HIV drug 22 September 2006 Update: Generic API biz to strengthen post deal says Matrix Labs CEO 28 August 2006 Mylan Labs to acquire Matrix Labs for $736 million 28 August 2006 Matrix to acquire controlling stake in Concord Biotech 06 December 2005 Matrix acquires 43 per cent stake in Swiss firm Explora Labs 21 September 2005 Matrix Labs acquires Belgian drug firm Docpharma for $263 m 20 June 2005 Matrix Labs gets US approval for second unit 13 March 2004 Divi''s, Matrix scrip prices cross leading pharma firms'' prices 29 December 2003 Matrix to merge Vorin, Medicorp with itself 16 September 2002  search domain-b    go
Legal Policy | Copyright © 1999-2011 The Information Company Private Limited. All rights reserved.